The global cell culture collagen market size was valued at USD 2.31 billion in 2024 and is predicted to hit around USD 4.19 billion by 2034, rising at a 6.15% CAGR, a study published by Towards Healthcare a sister firm of Precedence Research.
Ottawa, Nov. 26, 2025 (GLOBE NEWSWIRE) — The global cell culture collagen market size is calculated at USD 2.45 billion in 2025 and is expected to reach around USD 4.19 billion by 2034, growing at a CAGR of 6.15% for the forecasted period, driven by the expanding healthcare applications and growing innovations.
The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ https://www.towardshealthcare.com/download-sample/6346
Key Takeaways
- North America segment held a major revenue of approximately 38% share of the market in 2024.
- Asia Pacific segment is expected to witness the fastest growth in the cell culture collagen market between 2025-2034.
- By source, the bovine collagen segment held a major revenue of approximately 46% share of the market in 2024.
- By source, the human recombinant collagen segment is expected to witness the fastest growth in the market between 2025 to 2034.
- By product type, the type I collagen segment held a major revenue of approximately 52% share of the market in 2024.
- By product type, the type II & others segment is expected to witness the fastest growth in the market between 2025 to 2034.
- By application, the tissue engineering & regenerative medicine segment held a major revenue of approximately 38% share of the market in 2024.
- By application, the stem cell research segment is expected to witness the fastest growth in the market between 2025 to 2034.
- By form, the liquid collagen segment held a major revenue of approximately 45% share of the market in 2024.
- By form, the gel/hydrogel collagen segment is expected to witness the fastest growth in the market between 2025 to 2034.
- By end user, the pharmaceutical & biotechnology companies segment held a major revenue of approximately 40% share of the market in 2024.
- By end user, the others segment is expected to witness the fastest growth in the market between 2025 to 2034.
What is the Cell Culture Collagen?
The cell culture collagen market is driven by advancements in research areas like regenerative medicine and 3D cell culture models. The cell culture collagen refers to the specifically prepared and purified collagen for laboratory cell culture applications. They are used for cell adhesion, proliferation, 3D cell culture, tissue engineering, scaffolding, regenerative medicine, stem cell research, etc.
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
What are the Major Growth Drivers in the Cell Culture Collagen Market?
Growing R&D investments are the major growth driver in the market. This is accelerating the R&D activities and promoting other innovations, which are increasing the demand for cell culture collagen. Additionally, advancements in regenerative medicines, a shift towards 3D cell culture, alternatives to animal testing, and growing diseases are other market drivers.
What are the Key Drifts in the Cell Culture Collagen Market?
The market has been expanding due to the growing funding to launch and enhance the use of cell culture collagen for various applications.
- In October 2025, a new ten-million-yuan Series A+ financing round was announced to have been successfully completed by Meishangjie Biotechnology Co., Ltd., where this capital will be utilized to advance the clinical translation and market expansion of its recombinant humanized collagen products, continuously optimize its technology platforms, and accelerate R&D investment in genetic engineering and synthetic biology.
- In August 2025, a new equity financing round was announced to have closed with total funding of $137M, by Geltor, which will be used to advance its AI-enabled, animal-free bioactive proteins, after achieving a milestone, which was the launch of a vegan collagen polypeptide in Latin America.
What is the Significant Challenge in the Cell Culture Collagen Market?
High cost is a significant challenge in the market. The recombinant and specialty collagen types, equipment, and other reagents used in the research are expensive, which limits their use. Moreover, sourcing concerns, variability, risk of disease transmission, and regulatory hurdles are other market restraints.
Become a valued research partner with us – https://www.towardshealthcare.com/schedule-meeting
Regional Analysis
Why did North America Dominate the Cell Culture Collagen Market in 2024?
In 2024, North America captured the biggest revenue share of 38% in the market, due to growth in the R&D investments. The presence of robust healthcare also increased their adoption rates. Additionally, the growth in the use of advanced technologies and advancements in R&D also contributes to the market growth.
What Made Asia Pacific Grow Fastest in the Cell Culture Collagen Market in 2024?
Asia Pacific is expected to host the fastest-growing market during the forecast period, due to expanding industries. The growing investment and R&D are also increasing their demand, leading to new collaborations among industries and institutions. The growing demand for advanced therapies, increasing awareness, and affordability are also increasing their use, promoting the market growth.
Segmental Insights
By source analysis
Why Did the Bovine Collagen Segment Dominate in the Cell Culture Collagen Market in 2024?
By source, the bovine collagen segment led the market with approximately 46% share in 2024, due to its high availability. Their affordability and consistent quality also increased their use. Additionally, their good biochemical compatibility also increases their demand, which enhanced their innovations.
By source, the human recombinant collagen segment is expected to show the highest growth between 2025 to 2034, due to its compatibility. This is decreasing the immunogenicity, which is driving their R&D. Their consistency is also increasing their demand in the development of advanced therapies.
By product type analysis
Which Product Type Segment Held the Dominating Share of the Cell Culture Collagen Market in 2024?
By product type, the type I collagen segment held the dominating share of approximately 52% in the market in 2024, due to its easy sourcing and affordability. Moreover, their long history in R&D increased their preference. Their high reproducibility and robust structural properties increased their use in various R&D applications.
By product type, the type II & others segment is expected to show the fastest growth rate between 2025 to 2034, due to their growing use in various applications. The growing tissue engineering and regenerative medicine are also increasing their demand, which is accelerating disease modelling.
Get the latest insights on life science industry segmentation with our Annual Membership: https://www.towardshealthcare.com/get-an-annual-membership
By application analysis
What Made Tissue Engineering & Regenerative Medicine the Dominant Segment in the Cell Culture Collagen Market in 2024?
By application, the tissue engineering & regenerative medicine segment led the market with approximately 38% share in 2024, driven by growth in the R&D activities. The advancing pipeline and R&D investments also increased the demand for cell culture collagen, which contributed to the market growth.
By application, the stem cell research segment is expected to show the highest growth between 2025 to 2034, due to growing demand for regenerative therapies. The growing use of 3D stem cell cultures is also driving their demand, where advances in induced pluripotent stem cells are also contributing to the same.
By form analysis
Why Did the Liquid Collagen Segment Dominate in the Cell Culture Collagen Market in 2024?
By form, the liquid collagen segment held the largest share of approximately 45% in the market in 2024, driven by its easy use. Their compatibility with 3D cultures also increased their use in the development of scaffolds. Their flexibility and consistent quality also increased their use in various applications.
By form, the gel/hydrogel collagen segment is expected to show the fastest growth rate between 2025 to 2034, driven by its increased use in 3D cell cultures. Moreover, they are essential component for 3D bioprinting. Additionally, they are being used for tissue engineering and regenerative therapies.
By end-user analysis
How did the Pharmaceutical & Biotechnology Companies Segment Dominate the Cell Culture Collagen Market in 2024?
By end user, the pharmaceutical & biotechnology companies segment led the market with approximately 40% share in 2024, due to growth in the R&D investments. Furthermore, the growth in the assays, screening, 3D models, and regenerative platforms also increased their adoption rates, driving their use in various applications.
By end user, the others segment is expected to show the highest growth between 2025 to 2034, driven by expanding applications. The growing demand for personalized treatment options and outsourcing trends are also increasing their use. Additionally, the growing R&D is also increasing its demand.
Browse More Insights of Towards Healthcare:
The global cell culture microcarriers market size is calculated at USD 3.18 billion in 2024, grew to USD 3.45 billion in 2025, and is projected to reach around USD 7.2 billion by 2034. The market is expanding at a CAGR of 8.54% between 2025 and 2034.
The global cell culture vessels market size was evaluated at US$ 4.28 billion in 2024 and is expected to attain around US$ 17.59 billion by 2034, growing at a CAGR of 15.18% from 2024 to 2034.
The global cell culture media storage containers market size is calculated at US$ 2.15 in 2024, grow to US$ 2.42 billion in 2025, and is projected to reach around US$ 7.04 billion by 2034. The market is expanding at a CAGR of 12.59% between 2024 and 2034.
The global cell culture media market size is calculated at USD 6.9 billion in 2024, grew to USD 7.69 billion in 2025, and is projected to reach around USD 20.32 billion by 2034. The market is expanding at a CAGR of 11.45% between 2025 and 2034.
The global gene therapy cell culture media market size began at US$ 193.45 billion in 2024 and is forecast to rise to US$ 214.42 billion by 2025. By the end of 2034, it is expected to surpass US$ 541.42 billion, growing steadily at a CAGR of 10.84%.
The Europe cell culture media market is projected to reach USD 1642.05 million by 2034, growing from USD 948.32 million in 2025, at a CAGR of 6.29% during the forecast period from 2025 to 2034.
The global primary cell culture market size is expected to grow from USD 7.41 billion in 2025 to USD 20.62 billion by 2034, with a CAGR of 12.05% throughout the forecast period from 2025 to 2034.
The global bacterial cell culture market size is calculated at US$ 3.43 in 2024, grew to US$ 3.66 billion in 2025, and is projected to reach around US$ 6.56 billion by 2034. The market is expanding at a CAGR of 6.7% between 2025 and 2034.
The global viral vaccine cell culture media market size is calculated at USD 1.83 in 2024, grew to USD 1.94 billion in 2025, and is projected to reach around USD 3.24 billion by 2034. The market is expanding at a CAGR of 5.84% between 2025 and 2034.
The global insect cell lines market size is calculated at US$ 1.15 in 2024, grew to US$ 1.28 billion in 2025, and is projected to reach around US$ 3.39 billion by 2034. The market is expanding at a CAGR of 11.44% between 2025 and 2034.
Recent Developments in the Cell Culture Collagen Market
- In September 2025, a platform suitable for clinical trials, VECOLLAN®, which is a recombinant, non-animal-derived collagen-like protein platform, was launched by Evonik.
- In July 2025, the country’s first Collagen Water was launched by Aquatein in India, where it enhances skin hydration, antioxidant levels, UV protection, and joint health.
Cell Culture Collagen Market Key Players List
- Nippi Collagen Industries Ltd.
- Advanced BioMatrix Inc.
- Jellagen Ltd.
- Collagen Solutions plc
- Thermo Fisher Scientific Inc.
- FUJIFILM Wako Pure Chemical Corp.
- Merck KGaA
- Corning Incorporated
- Rousselot
- Cell Systems Corporation
- Rockland Immunochemicals Inc.
- BioVision Inc.
- TaKaRa Bio Inc.
- Koken Co., Ltd.
- AMS Biotechnology
- PeproTech
- CollPlant Biotechnologies Ltd.
- Matrix Bioscience GmbH
- 3D Matrix Medical Technology
- BioMatrix Specialty Collagen Products
Segments Covered in The Report
By Source
- Bovine Collagen
- Porcine Collagen
- Rat Tail Collagen
- Human Recombinant Collagen
- Fish/Marine Collagen
- Others
By Product Type
- Type I Collagen
- Type III Collagen
- Type IV Collagen
- Type V Collagen
- Type II & Others
By Application
- Tissue Engineering & Regenerative Medicine
- Drug Discovery & Toxicity Testing
- Cancer Research
- Stem Cell Research
- Others
By Form
- Liquid Collagen
- Powdered Collagen
- Gel/Hydrogel Collagen
- Sheets/Membranes/Sponges
By End User
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutions
- Contract Research Organizations (CROs)
- Cosmetic & Nutraceutical R&D Labs
- Others
By Region
North America
- U.S.
- Canada
- Mexico
- Rest of North America
South America
- Brazil
- Argentina
- Rest of South America
Europe
- Western Europe
- Germany
- Italy
- France
- Netherlands
- Spain
- Portugal
- Belgium
- Ireland
- UK
- Iceland
- Switzerland
- Poland
- Rest of Western Europe
- Eastern Europe
- Austria
- Russia & Belarus
- Türkiye
- Albania
- Rest of Eastern Europe
Asia Pacific
- China
- Taiwan
- India
- Japan
- Australia and New Zealand,
- ASEAN Countries (Singapore, Malaysia)
- South Korea
- Rest of APAC
MEA
- GCC Countries
- Saudi Arabia
- United Arab Emirates (UAE)
- Qatar
- Kuwait
- Oman
- Bahrain
- South Africa
- Egypt
- Rest of MEA
Immediate Delivery Available | Buy This Premium Research @ https://www.towardshealthcare.com/checkout/6346
Access our exclusive, data-rich dashboard dedicated to the healthcare market – built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.
Access the Dashboard: https://www.towardshealthcare.com/access-dashboard
About Us
Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth.
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
Europe Region: +44 778 256 0738
North America Region: +1 8044 4193 44
APAC Region: +91 9356 9282 04
Web: https://www.towardshealthcare.com
Our Trusted Data Partners
Precedence Research | Statifacts | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Consumer Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire | Nutraceuticals Func Foods | Onco Quant | Sustainability Quant | Specialty Chemicals Analytics
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | Pinterest
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.